Search This Blog

Saturday, 28 May 2016

Thermo: FEI deal will complement mass spec portfolio

Thermo Fisher Scientific is to buy FEI Company for $4.2bn saying it will drive adoption of FEI’s technologies among its life sciences customers, particularly in biopharma.



Read more about it via http://bit.ly/25rP1Dy

No comments:

Post a Comment